.brxe-button{width:auto}:where(.brxe-heading).has-separator{align-items:center;display:inline-flex;gap:20px}:where(.brxe-heading)>[contenteditable]{display:inline-block;text-decoration:inherit}:where(.brxe-heading) .separator{border-top:1px solid;flex-grow:1;flex-shrink:0;height:1px}/* BREAKPOINT: Desktop (BASE) */#brxe-ftucsq {font-size: 18px}/* BREAKPOINT: Desktop (BASE) */#brxe-survva {position: sticky; top: 135px; z-index: 50}/* BREAKPOINT: Tablet */@media (max-width: 1040px) {#brxe-survva {position: relative; top: 0px}}/* BREAKPOINT: Desktop (BASE) */#brxe-pbbjmq {padding-bottom: 0}/* BREAKPOINT: Desktop (BASE) */#what {background-image: linear-gradient(76deg, #185190 16%, #46C5E6 78%)}/* BREAKPOINT: Desktop (BASE) */#brxe-lakuqs {font-size: 12px; text-transform: uppercase; font-weight: 700}/* BREAKPOINT: Desktop (BASE) */#radiotherapeutics {background-position: bottom left; background-repeat: no-repeat; background-size: auto}/* BREAKPOINT: Desktop (BASE) */#insights {background-position: 90% 50%; background-repeat: no-repeat; background-size: 800px}